InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,751.93
(
0.11%
)
US TECH 100
19,527.60
(
-0.26%
)
Dow Jones
42,618.19
(
1.05%
)
Brent Oil
71.22
(
0.37%
)
Bitcoin
66,368.79
(
1.82%
)
Post# of 58465
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

3CTraderIsBack

Send PM Follow Ignore
Followers 61
Posts 5523
Boards Moderated 0
Alias Born 05/23/2007

3CTraderIsBack

Re: None

Wednesday, 01/28/2009 7:30:42 PM

Wednesday, January 28, 2009 7:30:42 PM

Post# of 58465
How can the FDA not approve this drug...

"...The long-term follow-up results from a Phase 3 trial, which evaluated Genasense in CLL, presented at the annual meeting of the American Society of Clinical Oncology in Chicago on June 2, 2008 were encouraging. According to the company, at 5 years, 45% of the patients in the Genasense group remain alive compared with 24% in the chemotherapy-only group...."
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up